Come si è arrivati alla scoperta dell’Idrogeno Molecolare? Qual è la sua storia? Che cosa ne pensano gli scienziati? Ecco qua tutte le risposte
Se hai letto l’ultimo articolo, sai che è stata fatta una nuova eccezionale scoperta sull’Idrogeno Diatomico o Molecolare, sul suo effetto anti-età e su ben 134 malattie nelle quali può agire a beneficio di chi lo assume. Troverai come puoi beneficiare anche tu degli incredibili vantaggi dell’Idrogeno molecolare alla fine di questo articolo.
Che cos’è l’Idrogeno Molecolare?
Se consideriamo la molecola dell’acqua, questa ha due atomi di idrogeno e uno di ossigeno (H2O). Se dividiamo la molecola dell’acqua, i due atomi di idrogeno si uniscono: questo è l’Idrogeno Diatomico o Molecolare (gas H2). Questa molecola d’idrogeno è la più piccola presente in natura e, per questo, può passare attraverso qualsiasi superficie. Grazie a questa caratteristica peculiare, è in grado di apportare i suoi effetti benefici a tutto l’organismo umano.
Come si è arrivati alla scoperta dei benefici terapeutici dell’idrogeno?
Ho scritto questo articolo proprio per approfondire la storia terapeutica dell’idrogeno e l’evoluzione della ricerca scientifica al riguardo. Stai per comprendere come siamo arrivati alla scoperta di cui si sta parlando tanto proprio ora, soprattutto in America.
Il parere degli scienziati
Tyler LeBaron del Molecular Hydrogen Institute(*), laureato in biochimica e professore di fisiologia presso la Southern Utah University, si occupa di ricerca sugli effetti terapeutici dell’idrogeno sin dal 2009. Ha svolto la sua attività di ricercatore in particolare presso l’Università di Nagoya in Giappone. Ecco che cosa ci dice sull’Idrogeno Molecolare:
“L’incidenza di malattie cardiovascolari, diabete, obesità e molti disordini neurologici aumentano in modo allarmante. La ricerca biomedica sul gas idrogeno sembra aver riscontrato un importante potenziale terapeutico. C’è tutta una serie di studi ben monitorati sull’uomo e oltre 300 articoli su riviste scientifiche sui benefici dell’idrogeno, alcuni pubblicati sui giornali più prestigiosi quali Nature e Science.
Adesso che gli effetti positivi dell’idrogeno sono stati confermati in quasi tutte le malattie umane, gli scienziati sono entusiasti e speranzosi a riguardo del suo impatto sul trattamento e la prevenzione delle malattie”.
Ci sono 3 semplici ragioni per cui l’idrogeno è utile:
1. L’idrogeno molecolare può convertire i radicali tossici dell’ossigeno in acqua. È la molecola più piccola, più piccola addirittura dell’ossigeno e può facilmente penetrare nelle cellule del mitocondrio meglio di qualsiasi altro antiossidante;
2. L’idrogeno permette un aumento degli antiossidanti naturali del nostro organismo come il GLUTATIONE e altri enzimi protettivi;
3. L’idrogeno ha un effetto benefico sui segnali, il metabolismo cellulare e l’espressione genetica, fornendo effetti antinfiammatori, antiallergici, anti età e antiobesità.”
Ma attraverso quali tappe si è passati per arrivare a questa scoperta?
La storia terapeutica dell’Idrogeno
Erodoto è stato il primo a riferirsi in maniera documentata a una mitica Fonte della Giovinezza. Resta da appurare se effettivamente ciò avesse a che fare o no con l’Idrogeno Molecolare, anche se le proprietà dell’una e dell’altro sembrano coincidere in maniera “sospetta”.
Andando avanti nel tempo, sembra che già nel 1798 si conoscessero le proprietà medicinali dell’idrogeno molecolare.
Molti anni dopo, nel 1975, i dipartimenti di Biologia e Chimica delle prestigiose Baylor University e Texas A&M hanno pubblicato sulla rivista Science, un importante articolo sul potenziale utilizzo dell’idrogeno molecolare in medicina.
Poi, si è dovuto attendere fino al 2007 per risvegliare l’interesse medico su questa materia, quando un articolo pubblicato su Nature Medicine ha mostrato le proprietà antiossidanti e l’attività antiapoptotica (cioè contro la morte cellulare) dell’idrogeno molecolare.
Prima del 2007, erano stati pubblicati solo 50 articoli sulle proprietà medicali dell’idrogeno. Negli ultimi 7 anni, ne sono stati pubblicati oltre 500!
Probabilmente, il motivo principale per cui solo ora l’idrogeno molecolare viene riconosciuto come molecola terapeutica è lo scetticismo scientifico. Infatti, è sempre stato difficile credere che l’idrogeno molecolare diatomico potesse avere effetti terapeutici, essendo considerato un gas inerte.
L’Idrogeno dalla notte dei tempi
L’idrogeno ha una storia intrigante. È il padre di tutti gli elementi dell’universo e, insieme all’ossigeno, è stato intrinsecamente coinvolto nell’evoluzione della vita.
Sono i due estremi costituiti dall’ossigeno e dall’idrogeno a fornire quell’equilibrio tra ossidazione e riduzione, che è fondamentale per la vita. E non sorprende che questa intima relazione tra ossigeno e idrogeno sia rimasta anche negli organismi superiori, come le piante, gli animali e gli esseri umani.
Tuttavia, fino a poco tempo fa, la ricerca si è concentrata solo sull’importanza e la tossicità dell’ossigeno, respingendo completamente il ruolo dell’idrogeno (che annulla la tossicità dell’ossigeno), concentrandosi solo su un lato di questa relazione di tipo Yin e Yang.
Vuoi godere anche tu dei benefici dell’Idrogeno Molecolare per la tua salute?
C’è un sistema molto efficace per sperimentare su di te gli effetti benefici dell’Idrogeno Molecolare: il trattamento Detox Profondo® di Addio Tossine.
In che modo Detox Profondo può aiutarti? Scoprilo qui nel dettaglio.
Inoltre, ho scritto un libro dove ti mostro come riuscire finalmente a vivere la tua vita in piena salute e con il pieno di energia. Puoi avere subito e gratis un estratto preziosissimo: clicca qui.
Quello che segue è il video straordinario che mostra questa scoperta eccellente: l’idrogeno molecolare è considerato un elisir di lunga vita.
In questo video puoi ascoltare l’interessante scoperta portata alla luce dal Dr. Tyler LeBaron. In questa intervista era un giovane scienziato; oggi è uno dei brillanti ricercatori del Molecolar Hydrogen Insitute, instancabile nella sua ricerca Scientifica sui benefici dell’Idrogeno Molecolare. Sembra un giovane ragazzo, ma più in basso, sotto al video, puoi vedere il numero incredibile delle sue pubblicazioni.
(*) PRESENTAZIONI/ PUBBLICAZIONI DI Tyler W. LeBaron
- 2022 Hasegawa T, Ito M, Hasegawa S, Teranishi M, Takeda K, Negishi S, Nishiwaki H, Takeda JI, LeBaron TW, Ohno K. Molecular Hydrogen Enhances Proliferation of Cancer Cells That Exhibit Potent Mitochondrial Unfolded Protein Response. International journal of molecular sciences. 2022 Mar 7;23(5):2888.
- 2021 Singh RB, Ghazi Halabi GF, Rai RH, Tarnava AT, LeBaron TW*. Molecular hydrogen as an adjuvant therapy may be associated with increased oxygen saturation and improved exercise tolerance in a COVID‐19 patient. Clinical Case Reports. 2021 Nov;9(11).
- 2021 Alwazeer D., Liu FF., WY Xiao., LeBaron TW*. Combating Oxidative Stress and Inflammation in COVID-19 by Molecular Hydrogen Therapy: Mechanisms and Perspectives. Oxidative Medicine and Cellular Longevity 2021
- 2021 LeBaron TW., Shigeo Ohta. Reply to “Discussion: Drinking hydrogen water enhances endurance and relieves psychometric fatigue: a randomized, double-blind, placebo-controlled study”1 Can. J. Physiology and Pharmacology. 99(10), pp.1114-1115.
- 2021 LeBaron TW*., Kharman J. Michael L. McCullough. An H2-infused, nitric oxide-producing functional beverage as a neuroprotective agent for TBIs and concussions. J. Integrative Neuroscience 20, no. 3 (2021): 667-676.
- 2021 Hancock, J.T., LeBaron, TW., May, J., Thomas, A., Russell, G. Molecular Hydrogen: a new treatment for plants in the UK? New Trends in UK Plant Science Plants 10, no. 11 (2021): 2270.
- 2021 LeBaron TW., Asgharzadeh F., Khazei M., Kura B., Tarnava A., Slezak J., Molecular hydrogen is comparable to sulfasalazine as a treatment for DSS-induced ulcerative colitis in mice. EXCLI Journal, 20:1106-1117
- 2021 LeBaron TW*., Kharman J. Michael L. McCullough. Effects of an H2-infused, nitric oxide-producing functional beverage on exercise and cognitive performance. Journal of Science and Medicine, 3(2)p79
- 2021 Hancock, J.T., LeBaron, T.W. and Russell, G., 2021. Molecular Hydrogen: Redox Reactions and Possible Biological Interactions. Reactive Oxygen Species, 11, pp.m17-m25.
- 2020 Barancik A., Kura B., LeBaron TW., Bolli R., Buday J., Slezak J. Molecular mechanisms and cellular systems associated with the medical effects of molecular hydrogen. Antioxidants, 9(12), p.1281.
- 2020 Slezak J, Kura B, LeBaron TW, Singal PK, Buday J, Barancik M. Oxidative stress and pathways of molecular hydrogen effects in medicine. Current Pharmaceutical Design. 2020. 26, 1-16
- 2020 T.W. LeBaron, M.L. McCullough, K.H. Ruppman Sr. 2020 A novel functional beverage for COVID-19 and other conditions: hypothesis and preliminary data, increased blood flow, and wound healing J Transl Sci, 6 (2020), pp. 1-6
- 2020 LeBaron, T.W., Singh, R.B., Fatima, G., Kartikey, K., Sharma, J.P., Ostojic, S.M., Gvozdjakova, A., Kura, B., Noda, M., Mojto, V. and Niaz, M.A., 2020. The Effects of 24-Week, High-Concentration Hydrogen-Rich Water on Body Composition, Blood Lipid Profiles and Inflammation Biomarkers in Men and Women with Metabolic Syndrome: A Randomized Controlled Trial. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13, p.889.
- 2020 Zhang X, Zhang Z, Su Z, Zhao Q, LeBaron TW, Li Q, Lyu B, Adzavon YM, Liu G, Liu M, Xie F. Hydrogen evolution and absorption phenomena in plasma membrane of higher plants. bioRxiv. 2020 Jan 1.
- Korovljev, D., Stajer, V., Ostojic, J., LeBaron, T.W. and Ostojic, S.M., 2019. Hydrogen-rich water reduces liver fat accumulation and improves liver enzyme profiles in patients with non-alcoholic fatty liver disease: a randomized controlled pilot trial. Clinics and Research in Hepatology and Gastroenterology, 43(6), pp.688-693.
- 2019 LeBaron, T.W., Kura, B., Kalocayova, B., Tribulova, N. and Slezak, J., 2019. A new approach for the prevention and treatment of cardiovascular disorders. Molecular hydrogen significantly reduces the effects of oxidative stress. Molecules, 24(11), p.2076.
- 2019 Mikami, T., Tano, K., Lee, H., Lee, H., Park, J., Ohta, F., LeBaron, T.W. and Ohta, S., 2019. Drinking hydrogen water enhances endurance and relieves psychometric fatigue: a randomized, double-blind, placebo-controlled study. Canadian journal of physiology and pharmacology, 97(9), pp.857-862
- 2019 LeBaron TW, Laher, I., Kura, B., & Slezak, J. Hydrogen gas: from clinical medicine to an emerging ergogenic molecule for sports athletes. Canadian journal of physiology and pharmacology, 2019; 97(9), pp.857-862
- 2019 Korovljev, D., Stajer, V., Ostojic, J., LeBaron, T.W. & Ostojic, S.M., 2019. Hydrogen-rich water reduces liver fat accumulation and improves liver enzyme profiles in patients with non-alcoholic fatty liver disease: a randomized controlled pilot trial. Clinics and research in hepatology and gastroenterology. 2019 April (in press)
- 2019 LeBaron TW, Larson A, Ohta S, Mikami T, Barlow J, Bulloch J, Debeliso M. Acute Supplementation with Molecular Hydrogen Benefits Submaximal Exercise Indices. Randomized, Double-Blinded, Placebo-Controlled Crossover Pilot Study. J. Lifestyle Medicine 2019; 9:36-43
- 2019 Kura B, Kalocayova B, LeBaron TW, Frimmel K, Buday J, Surovy J, Slezak J. Regulation of microRNAs by molecular hydrogen contributes to the prevention of radiation-induced damage in the rat myocardium. Molecular and Cellular Biochemistry. 2019 Mar 4:1-2.
- 2018 Kura B, Bagchi AK, Singal PK, Barancik M, LeBaron TW, Valachova K, Soltes L, Slezak J. Molecular hydrogen (H2): Potential in mitigating oxidative stress-induced cardiotoxicity. Canadian journal of physiology and pharmacology. 2018 Dec 13(ja).
- 2018 Jackson K, Dressler N, Ben-Shushan RS, Meerson A, LeBaron TW, Tamir S. Effects of alkaline-electrolyzed and hydrogen-rich water, in a high-fat-diet nonalcoholic fatty liver disease mouse model. World Journal of Gastroenterology. 2018 Dec 7;24(45):5095.
- 2018 Tyler W. LeBaron; Special Lecture: “Therapeutic and clinical effects of hydrogen gas” * Japanese-English translation, presented at medical-dental conference in Tokyo Japan (Dec. 15, 2018).
- 2018 Guo Q, Yin X, Qiao M, Jia Y, Chen D, Shao J, LeBaron TW, Gao Y, Jia B, Shi H. Hydrogen-rich water ameliorates autistic-like behavioral abnormalities in valproic acid-treated adolescent mice offspring. Frontiers in behavioral neuroscience. 2018;12:170.
- 2018 Tyler W. LeBaron; “Clinical effects of molecular hydrogen on neurodegenerative diseases” presented at Academy of Comprehensive Integrative Medicine. Orlando, Florida (Nov. 10th, 2015)
- 2018 Hirayama M, Ito M, Minato T, Yoritaka A, LeBaron TW, Ohno K. Inhalation of hydrogen gas elevates urinary 8-hydroxy-2′-deoxyguanine in Parkinson’s disease. Medical gas research. 2018 Oct;8(4):144.
- 2018 Tyler W. LeBaron; “Inhalation of hydrogen gas mildly elevates oxidative stress in Parkinson’s disease. Hormetic or toxic?” presented at first International conference on Hydrogen Medicine and Biology Beijing China Oct. 13, 2018.
- 2018 Tyler W. LeBaron; “Beneficial effects of hydrogen gas- involvement of miRNAs, Co-Q10 and ATP production presented at the International Hydrogen Industry Development Forum, organized by International Molecular Hydrogen Association (IMHA) in Guangzhou, China (Sept. 15, 2018)
- 2018 Shang L, Xie F, Li J, Zhang Y, Liu M, Zhao P, Ma X, LeBaron TW. Therapeutic potential of molecular hydrogen in ovarian cancer. Translational Cancer Research. 2018 Aug 14;7(4):988-95.
- 2018 Tyler W. LeBaron; “Practical Applications and Clinical Uses for Molecular Hydrogen” presented at SOPMED Medical Conference in Colorado Springs, Colorado (June 22nd, 2018)
- 2018 Tyler W. LeBaron “Hydrogen: a therapeutic molecule for cardio and cerebrovascular diseases” presented at the 5th European Section meeting of the International Academy of Cardiovascular Sciences (IACS-ES) in Bratislava, Slovakia (May 24, 2018).
- 2018 M. Liang; Y. Du; W. Li; X. Yin; N. Yang; A. Qie; T. W. LeBaron; J. Zhang; H. Chen; H. Shi. “SuHeXiang essential oil inhalation produces antidepressant- and anxiolytic-like effects in adult mice” Biological and Pharmaceutical Bulletin. 2018 May 9:b18-00082
- 2018 Tyler W. LeBaron & Mark Rosenberg “Clinical Applications for Molecular Hydrogen” presented at the Academy of Anti-Aging Medicine (A4M) in Hollywood, Florida (April13, 2018).
- 2018 Tyler W. LeBaron; “Hydrogen: a biologically-regenerative molecule with clinical applications” presented at the Academy of Regenerative Practices in Boca Raton, Florida (March 3, 2018).
- 2017 Tyler W. LeBaron; “Is Hydrogen an Antioxidant? Definitions and Explanations” presented at the 4th Symposium of CPAM Chinese Hydrogen Biomedical Association (SCHBA) in Foshan, China (Dec. 6, 2017).
- 2017 Tyler W. LeBaron; “Hydrogen: an emerging medical gas with clinical significance” presented at 22nd International Conference of FFC-10th International Symposium of ASFFBC at Harvard Medical School, Boston MA, USA. (Sept. 23, 2017).
- 2017 Tyler W. LeBaron; “Molecular Hydrogen: from basic and clinical research to sports performance; an overview of the data from recent human studies” presented at the International Hydrogen Industry Development Forum, organized by International Molecular Hydrogen Association (IMHA) in Guangzhou, China (Sept. 14, 2017)
- 2017 Gao, Q., Song, H., Wang, X.T., Liang, Y., Xi, Y.J., Gao, Y., Guo, Q.J., LeBaron, T., Luo, Y.X., Li, S.C. and Yin, X. Molecular hydrogen increases resilience to stress in mice. Nature publication: Scientific Reports, 7 (2017)
- 2017 Tyler W. LeBaron; “Hydrogen: signal modulator for disease and inflammation” presented at SOPMED Medical Conference in Colorado Springs, Colorado (June 16th, 2017)
- 2017 Tyler W. LeBaron; “Hydrogen: A Therapeutic Medical Gas” presented at conference and medical group in Jakarta Indonesia (March 8, 2017)
- 2016 Tyler W. LeBaron; “Hydrogen Revolution in Industry and Medical Biology” presented at the Korea International Symposium on Hydrogen in Seoul Korea (November 25, 2016)
- 2016 Tyler W. LeBaron; “Hydrogen: A Small Molecule with Great Clinical Significance” presented at ILADS Annual Scientific Medical Conference on Lyme Disease in Philadelphia, PA (November 5, 2016)
- 2016 Tyler W. LeBaron; “Hydrogen: an Ageless Molecule of an Aging Society; a Scientific Basis for the Amelioration of Inflammation, Oxidation, and Cellular Degeneration” presented at the 3rd Symposium of Chinese Hydrogen Biomedical Association (SCHBA) in Taian city (September 25, 2016)
- 2016 Tyler W. LeBaron; “Hydrogen: an explosive molecule with explosive therapeutic effects” presented at the International Hydrogen Industry Development Forum, organized by International Molecular Hydrogen Association (IMHA) in Guangzhou, China (Sept. 9, 2016)
- 2016 Tyler W. LeBaron; “Hydrogen: A Therapeutic Molecule with Ergogenic Potential” presented at the 6th Hydrogen Medicine Conference in Shenyang, China (July 24, 2016)
- 2016 Tyler W. LeBaron; “Hidrógeno molecular: La revolución de Salud y el Bienestar, presented at Global Conference in Querétaro Mexico (July 12th, 2016)
- 2016 Tyler W. LeBaron; “Hydrogen Therapy: ‘Primum non nocere’ a revolution in health and wellness” presented at SOPMED Medical Conference in Salt Lake City, Utah (June 17th, 2016)
- 2016 Tyler W. LeBaron; “Hydrogen: A Unique and Superior Antioxidant Molecule for Athletes” presented at the International Molecular Hydrogen Symposium in Shanghai (March 20, 2016)
- 2015 Tyler LeBaron; “Molecular Hydrogen: therapeutic and medical applications” presented at Age Management Medical Group. Las Vegas, Nevada (Dec. 8th, 2015).
- 2015 Tyler LeBaron; “Molecular Hydrogen: therapeutic potential for neurodegenerative diseases” presented at Academy of Comprehensive Integrative Medicine. Orlando, Florida (Oct. 24th, 2015)
- 2015 Tyler LeBaron; “Molecular Hydrogen: therapeutic and medical applications” presented at FIME Medical Expo. Miami, Florida. (Aug. 7th, 2015).
- 2015 Tyler W. LeBaron; “Molecular Hydrogen: an evolutionary and molecular explanation for its ubiquitous biological effects on eukaryotes” presented at the 2nd Molecular Hydrogen Biomedical Symposium. CPMA Chinese Hydrogen Biomedical Association(June 28, 2015)
- 2015 Tyler W. LeBaron; “Molecular Hydrogen in America: research, products, media, and awareness” presented at 5thSymposium of Medical Molecular Hydrogen at Nagoya University (March 22, 2015) http://www.med.nagoya-u.ac.jp/neurogenetics/mmh2015/sub_program.html
- 2014 Meyers, Jonathan K., Tyler W. LeBaron, and David C. Collins. “The Journal of Kitchen Chemistry: A Tool for Instructing the Preparation of a Chemistry Journal Article.” Journal of Chemical Education. http://pubs.acs.org/doi/abs/10.1021/ed400671y
- 2013 Tyler W. LeBaron; “Changes in Oxidation-Reduction Potential of Aqueous Solutions as a Function of pH and Hydrogen Gas Concentration” The Journal of Kitchen Chemistry 2013. 1. P.12
- 2013 Tyler W. LeBaron; “Estimation of Hydrogen gas Concentration in Aqueous Solutions via Oxidation-Reduction Potential Measurements as a Function of pH” presented at BYU-I Research and Creative Works Conference, April 4, 2013. http://beta.byui.edu/Documents/instructional_development/rcw/2013%20Winter/RCW%20Winter%202013%20%282%29.pdf
- 2012 Tyler W. LeBaron; Determination of nitrate reduction in the presence of ascorbic acid at facilitative pH (Personal project—preliminary results and specific review presented in 2012).
- 2012 Tyler W. LeBaron; “Testosterone Booster Recommendation Report” (A critical review of purported supplements) http://scholar.google.com/scholar?q=%22Testosterone+Booster+Recommendation+Report%22&btnG=&hl=en&as_sdt=0%2C13
- 2011 Tyler W. LeBaron; “Creatine recommendation report” (Review of current work and elucidation of creatine stability with respect to various supplements http://scholar.google.com/scholar?q=%22creatine+recommendation+report%22+&btnG=&hl=en&as_sdt=0%2C13
- 2010 Tyler W. LeBaron; “Functional Water for the Prevention and Treatment of Disease (A comprehensive literature review)”, presented at BYU-I Research and Creative Works Conference, December 9, 2010. http://emp.byui.edu/PyperB/2010FallUGRC.htm
- 2010 Tyler W. LeBaron “Alkaline Reduced (electrolyzed) Water enhances time to exhaustion during lactate threshold running”, presented at BYU-I Research and Creative Works Conference, Mar 25, 2010 http://emp.byui.edu/PyperB/2010byuiugrc.htm
0 commenti